293 related articles for article (PubMed ID: 30359426)
1. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential.
Friesen WJ; Johnson B; Sierra J; Zhuo J; Vazirani P; Xue X; Tomizawa Y; Baiazitov R; Morrill C; Ren H; Babu S; Moon YC; Branstrom A; Mollin A; Hedrick J; Sheedy J; Elfring G; Weetall M; Colacino JM; Welch EM; Peltz SW
PLoS One; 2018; 13(10):e0206158. PubMed ID: 30359426
[TBL] [Abstract][Full Text] [Related]
2. Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin.
Floquet C; Hatin I; Rousset JP; Bidou L
PLoS Genet; 2012; 8(3):e1002608. PubMed ID: 22479203
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
[TBL] [Abstract][Full Text] [Related]
4. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.
Wangen JR; Green R
Elife; 2020 Jan; 9():. PubMed ID: 31971508
[TBL] [Abstract][Full Text] [Related]
5. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough.
Hosseini-Farahabadi S; Baradaran-Heravi A; Zimmerman C; Choi K; Flibotte S; Roberge M
PLoS Biol; 2021 May; 19(5):e3001221. PubMed ID: 33939688
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM; Bedwell DM
J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
[TBL] [Abstract][Full Text] [Related]
7. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
8. Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
Howard MT; Anderson CB; Fass U; Khatri S; Gesteland RF; Atkins JF; Flanigan KM
Ann Neurol; 2004 Mar; 55(3):422-6. PubMed ID: 14991821
[TBL] [Abstract][Full Text] [Related]
9. Stop codon readthrough as a treatment option for epidermolysis bullosa-Where we are and where we are going.
Zandanell J; Wießner M; Bauer JW; Wagner RN
Exp Dermatol; 2024 Mar; 33(3):e15042. PubMed ID: 38459626
[TBL] [Abstract][Full Text] [Related]
10. Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.
Matalonga L; Arias Á; Tort F; Ferrer-Cortés X; Garcia-Villoria J; Coll MJ; Gort L; Ribes A
Neurotherapeutics; 2015 Oct; 12(4):874-86. PubMed ID: 26169295
[TBL] [Abstract][Full Text] [Related]
11. Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model.
Du M; Keeling KM; Fan L; Liu X; Bedwell DM
J Biol Chem; 2009 Mar; 284(11):6885-92. PubMed ID: 19136563
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon.
Fuchshuber-Moraes M; Carvalho RS; Rimmbach C; Rosskopf D; Carvalho MA; Suarez-Kurtz G
Pharmacogenet Genomics; 2011 Nov; 21(11):694-700. PubMed ID: 21934639
[TBL] [Abstract][Full Text] [Related]
13. The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients.
Simon AJ; Lev A; Wolach B; Gavrieli R; Amariglio N; Rosenthal E; Gazit E; Eyal E; Rechavi G; Somech R
PLoS One; 2010 Nov; 5(11):e13659. PubMed ID: 21103413
[TBL] [Abstract][Full Text] [Related]
14. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
[TBL] [Abstract][Full Text] [Related]
15. 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases.
Bidou L; Bugaud O; Merer G; Coupet M; Hatin I; Chirkin E; Karri S; Demais S; François P; Cintrat JC; Namy O
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2122004119. PubMed ID: 35994666
[TBL] [Abstract][Full Text] [Related]
16. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
[TBL] [Abstract][Full Text] [Related]
17. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
Ferguson MW; Gerak CAN; Chow CCT; Rastelli EJ; Elmore KE; Stahl F; Hosseini-Farahabadi S; Baradaran-Heravi A; Coltart DM; Roberge M
PLoS One; 2019; 14(5):e0216423. PubMed ID: 31120902
[TBL] [Abstract][Full Text] [Related]
18. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.
McHugh DR; Cotton CU; Hodges CA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396210
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal dementia non-sense mutation of progranulin rescued by aminoglycosides.
Kuang L; Hashimoto K; Huang EJ; Gentry MS; Zhu H
Hum Mol Genet; 2020 Mar; 29(4):624-634. PubMed ID: 31913476
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
Malik V; Rodino-Klapac LR; Viollet L; Wall C; King W; Al-Dahhak R; Lewis S; Shilling CJ; Kota J; Serrano-Munuera C; Hayes J; Mahan JD; Campbell KJ; Banwell B; Dasouki M; Watts V; Sivakumar K; Bien-Willner R; Flanigan KM; Sahenk Z; Barohn RJ; Walker CM; Mendell JR
Ann Neurol; 2010 Jun; 67(6):771-80. PubMed ID: 20517938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
